In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

(BPT) - Looking for ways to slim down and improve your health? You've probably heard about GLP-1s — the buzzworthy prescription medication behind some of today's most talked-about weight loss stories.

Half of diabetic patients aged 65 and older in the United States who use GLP-1 class obesity treatments discontinue therapy ...

Diccon Hyatt is an experienced financial and economics reporter. He's written hundreds of articles breaking down complex financial topics in plain language, emphasizing the impact that economic ...

President Donald Trump announced a deal Thursday, Nov. 6 with drugmakers Eli Lilly and Novo Nordisk to cut prices of their popular weight-loss drugs and expand Medicare coverage of these medications ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, users are stocking up on supplies and fretting about the future of their treatment. Over the past few years, ...